drug
NOUS-209
Phase 2updated 6mo agoby Nouscom AG
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(2)
- Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness studyRoche is paying Hansoh $400 million up front in a broad deal involving several ADCs. Elsewhere, another top investor formed a China-focused fund and Ultragenyx sold a second review voucher.biopharma_dive · 29d ago
- Nouscom raises $135M for pivotal trial of cancer-preventing vaccine candidateNouscom has reeled in 120 million euros ($135 million) to take a cancer-preventing vaccine through a registration-enabling clinical trial.fiercebiotech · 1mo ago
Data sources
last refreshed 44m ago
Found something off?
comments(0)
5-min edit window · permanent after that